Nerve Repair and Regeneration Market: Technological Advancements in Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps & Neurostimulation Devices | Trends 2018

The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Browse and in-depth TOC on “Nerve Repair and Regeneration Market”

83 - Tables

31 - Figures

122 - Pages

View more detailed TOC @

http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html



By neurostimulation and neuromodulation device product, the internal neurostimulation device segment is expected to dominate the market in 2017
On the basis of neurostimulation and neuromodulation device product is subsegmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

By end user, the hospitals and clinics segment is expected to dominate the market in 2017
In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=883

Asia offers lucrative growth opportunities

By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period.

The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.

 

Healthcare CRM Market outlook with industry review and forecasts

According to the new market research report "Healthcare CRM Market by Component (Software, Service), Delivery (On premise, Cloud, Public, Private, Hybrid), End user (Hospital, ASC, Payers, Life Science), Functionality (CSS, Marketing, Sales, Digital Marketing, AI, Analytics) - Global Forecast to 2023", published by MarketsandMarkets™, the Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period.

The benefits of CRM software and a growing focus on patient engagement are the major factors driving the growth of the Healthcare CRM Market.
Healthcare providers are expected to dominate the healthcare CRM end-user market in 2018

Based on end user, the Healthcare CRM Market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the Healthcare CRM Market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions. Moreover, there is a growing focus on patient engagement, which is again likely to drive the market for this segment.

Browse in-depth TOC on "Healthcare CRM Market"
62 - Tables
34 - Figures
121 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/healthcare-crm-market-88873203.html

Healthcare CRM services to grow at the highest CAGR during 2018-2023
On the basis of component, the Healthcare CRM Market is segmented into software and services. The services segment is expected to dominate the Healthcare CRM Market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the Healthcare CRM Market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. In terms of IT usage and skills, the healthcare industry is still in the nascent stage; it relies heavily on service providers for CRM-related services and support services, such as implementation, integration, training and education, maintenance, and technology upgrades. The recurring need for services such as software upgrades and maintenance is the key factor supporting the growth of this segment.

Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=88873203  

North America to dominate the market, followed by Europe
Geographically, the global Healthcare CRM Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the Healthcare CRM Market.

The key players in the Healthcare CRM Market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US).

Chromatography Instruments Market Worth 10.99 Billion USD by 2022

According to a new market research report "Chromatography Instruments Market by Type (Systems, Detectors), Consumables (Columns) and Accessories (Auto-sampler Accessories), Applications (Life science Research, Environmental Testing, Food & Beverage Testing), and Region - Global Forecast to 2022" published by MarketsandMarkets™, the market is expected to reach USD 10.99 Billion by 2022 from an estimated USD 7.86 Billion in 2017, at a CAGR of 6.9%.

Browse 160 Market Data Tables and 40 Figures spread through 245 Pages and in-depth TOC on "Chromatography Instruments Market"

http://www.marketsandmarkets.com/Market-Reports/chromatography-instrumentation-market-1258.html

Early buyers will receive 10% customization on this report.
The key factors driving the growth of this market include the rising food safety concerns, increasing use of chromatography tests in the drug approval process, and growing popularity of hyphenated chromatography techniques. However, the high cost of equipment is likely to restrain the growth of the market during the forecast period.

By type, the systems segment accounted for the largest share of the market in 2017
On the basis of type, the Chromatography Instruments Market is broadly segmented into systems, detectors, auto-samplers, and fraction collectors. In 2017, the systems segment is expected to account for the largest share of this market and is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the growing importance of chromatography tests in drug approvals.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1258

By consumables and accessories, the consumables segment held the largest market share in 2017
The Chromatography Instruments Market is further classified into consumables and accessories. In 2017, the consumables segment is expected to account for the largest share of the Chromatography Instruments Market and is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is mainly attributed to the rise in the food safety concerns.

By application, the life science industry held the largest market share in 2017
Based on application, the Chromatography Instruments Market is further segmented into life science, environmental testing, food and beverage testing, and other applications. In 2017, the life science industry segment is expected to account for the largest share and is expected to grow at the highest CAGR during the forecast period. Chromatography tests in drug approvals and increasing popularity of hyphenated techniques are the major factors driving the growth of this segment.

Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1258

North America dominated the market in 2017
North America accounted for the largest share of the Chromatography Instruments Market in 2016, followed by Europe. The increase in funding for R&D activities in the healthcare industry and increasing number of conferences in the U.S. are some of the major factors driving the growth of the market in the U.S. The growth of the Canadian food testing industry will also drive market growth during the forecast period.
Factors such as rising importance of food safety in the U.K., growth of the cosmetics industry in France, and the increase in R&D expenditure in the pharmaceutical industry in the RoE are expected to boost the adoption of chromatography instruments in European countries; generating a significant growth opportunity for the players competing in the global Chromatography Instruments Market during the forecast period.

The key players in the market include Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific Inc. (U.S.), and PerkinElmer Inc. (U.S.)

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
+1-888-600-6441
Email: sales@marketsandmarkets.com

Ophthalmic Equipment Market Worth 58.44 Billion USD by 2023

According to a new market research report "Ophthalmic Equipment Market (Optical Coherence Tomography (OCT), Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Femtosecond Laser, Surgical Microscope, Contact Lenses) - Global Forecasts to 2023", published by MarketsandMarkets™, the market is projected to reach USD 58.44 Billion by 2023 from USD 49.30 Billion in 2018, at a CAGR of 3.5%.

Browse 361 market data Tables and 46 Figures spread through 361 Pages and in-depth TOC on "Ophthalmic Equipment Market"

https://www.marketsandmarkets.com/Market-Reports/ophthalmology-devices-market-155637364.html
 
Early buyers will receive 10% customization on reports
Growth in this market is attributed to the growing number of people with eye diseases, technological advancement in ophthalmic equipment, and the rising adoption of contact lenses and spectacles across the globe.

The optical coherence tomography (OCT) scanners segment to dominate the ophthalmology diagnostic and monitoring devices market during the forecast period
Based on diagnostic and monitoring devices type, the ophthalmic equipment market is segmented into optical coherence tomography (OCT) scanners, ophthalmic ultrasound imaging systems, fundus cameras, ophthalmoscopes, retinoscopes, wavefront aberrometers, corneal topography systems, autorefractors and keratometers, phoropters, specular microscopes, perimeter/visual field analyzers, tonometers, slit lamps, lensmeters, optical biometry systems, and chart projectors. The OCT scanners segment accounted for the major share of the ophthalmology diagnostic and monitoring devices market and this segment is expected to register the highest growth during the forecast period. The large share and high growth of this segment can primarily be attributed to the rising geriatric population and the subsequent increase in the prevalence of ocular diseases and increasing number of research and development activities in this field.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=155637364

The glaucoma surgical devices segment to witness the highest growth rate during the forecast period
On the basis of ophthalmology surgical devices type, the ophthalmic equipment market is segmented into cataract surgical devices, glaucoma surgical devices, refractive surgical devices, vitreoretinal surgical devices, ophthalmic microscopes, and accessories. The cataract surgical devices segment accounted for the major share of the ophthalmology surgical devices market. The large share of this segment is majorly attributed to the growing number of eye disorders in the geriatric population. The glaucoma surgical devices segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the rising prevalence of glaucoma across the globe coupled with the availability of technologically advanced microinvasive glaucoma surgeries.

The spectacles segment dominated the vision care products market in 2017
On the basis of type, the vision care products market is segmented into spectacles and contact lenses. In 2017, the spectacles segment accounted for the major share of the vision care products market. The large share of this segment can be attributed to their higher adoption for vision correction as well as innovations in eyeglasses.

North America dominated the market in 2017
North America accounted for the largest share of the ophthalmic equipment market in 2017, followed by Europe. The large share of this region is attributed to the presence of developed healthcare systems in the US & Canada, increasing number of eye disorders along with rising aging population, and availability of technologically advanced ophthalmic devices.
The prominent players in the ophthalmic equipment market are Essilor (France), Alcon (Switzerland), Johnson & Johnson Vision Care (US), Bausch + Lomb (US), Haag-Streit (Switzerland), TOPCON (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan), STAAR Surgical (US), HOYA (Japan), and Ziemer Ophthalmic Systems (Switzerland)

Know more about the Ophthalmic Equipment Market:
https://www.marketsandmarkets.com/Market-Reports/ophthalmology-devices-market-155637364.html
  
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Organs-on-chips Market Worth 45.6 Million USD by 2022

According to a new market research report "Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%.

The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.

Browse 68 market data Tables and 27 Figures spread through 117 Pages and in-depth TOC on "Organs-on-chips Market"
https://www.marketsandmarkets.com/Market-Reports/organs-on-chips-market-144117291.html

Early buyers will receive 10% customization on this report

The liver-on-a-chip segment is expected to dominate the market in 2017
Based on type, the Organs-on-chips Market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the Organs-on-chips Market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=144117291

The drug discovery segment is expected to register the highest CAGR during the forecast period.
Based on application, the Organs-on-chips Market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period. The increasing focus on drug discovery, rising need for more predictive in vitro tools for drug development among pharmaceutical companies, and growing preference for alternatives to conventional cell culture and animal models are some of the factors that are driving the growth of the drug discovery segment.

North America to dominate the Organs-on-chips Market
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as availability of new and advanced organs-on-chips in the market, and favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies. These are regions where the majority of drug development activity is concentrated.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=144117291

The Organs-on-chips Market is emerging and high growth potential market with the presence of several small players and startups firms. Some of the players in the Organs-on-chips Market include Emulate (US), CN Bio (UK), TissUse (Germany), Mimetas (Netherlands), InSphero (Switzerland), Ascendance Bio (US), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit Our Blog: http://mnmblog.org/market-research/healthcare/biotechnology

Slide Stainer Market Worth 4.70 billion USD by 2023

According to a new market research report "Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%. The major factors driving the growth of this market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.

Browse 104 market data Tables and 30 Figures spread through 140 Pages and in-depth TOC on "Slide Stainer Market"

https://www.marketsandmarkets.com/Market-Reports/slide-stainer-market-134046412.html

Early buyers will receive 10% customization on this report

By product, the reagents segment accounted for the largest share of the Slide Stainers Market in 2017
On the basis of product, the reagents segment accounted for the largest share of the global Slide Stainers Market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

By technology, the hematoxylin & eosin (H&E) segment held the largest share in 2017
Based on technology, the Slide Stainers Market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the Slide Stainers Market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=134046412

By end user, the hospitals and diagnostic centers segment held the largest share of the Slide Stainers Market in 2017
On the basis of end user, the Slide Stainers Market is segmented into hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies and other end users (contract research organizations and forensics, food, & environmental laboratories). The hospitals and diagnostic centers segment accounted for the largest share in 2017. Factors such as the growing prevalence of diseases and huge patient inflow in hospitals and diagnostic centers are driving the growth of this end-user segment.

North America dominated the market in 2017
North America accounted for the largest share of the Slide Stainers Market in 2017, followed by Europe and Asia Pacific. The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American Slide Stainers Market.
The prominent players in the global Slide Stainer Market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).

Know more about the Slide Stainer Market:

https://www.marketsandmarkets.com/Market-Reports/slide-stainer-market-134046412.html

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
 
Contact:

Mr. Shelly

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Autoinjectors Market Worth $85.31 Billion by 2023

According to a new market research report 'Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023', published by MarketsandMarkets™, the global market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).

Browse 66 market data Tables and 36 Figures spread through 133 Pages and in-depth TOC on 'Autoinjectors Market'

https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html

Early buyers will receive 10% customization on this report
The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.

By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018
On the basis of therapy, the Autoinjectors Market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies such as migraines, cardiovascular diseases, psoriasis, and anemia. In 2018, the rheumatoid arthritis segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

By type, the disposable autoinjectors segment is expected to account for the largest share of the market in 2018
On the basis of type, the Autoinjectors Market is segmented into disposable and reusable autoinjectors. In 2018, the disposable autoinjectors segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to their ease of use and minimal risk of infection.

By end user, the home care settings segment is expected to account for the largest share of the market in 2018
On the basis of end user, the Autoinjectors Market is segmented into home care settings and hospitals & clinics. In 2018, home care settings segment is expected to account for the largest share of the global market. A majority of autoinjectors are used for self-administration of drugs and are rarely recommended for hospital use to avoid the risk of infection due to use on multiple patients. This is a major factor driving market growth. Other factors such as the growing prevalence of chronic diseases and technological advancements are also supporting growth in this market segment.

Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=173991724

North America to dominate the market in 2018
In 2018, North America is expected to account for the largest share of the Autoinjectors Market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.
The key players in the global Autoinjectors Market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).

Know more about the Autoinjectors Market:
https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the 'Growth Engagement Model - GEM'. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write 'Attack, avoid and defend' strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, 'Knowledge Store' connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/autoinjector-market.asp

Insulin Pens Segment Commanded the Largest Share of the Insulin Delivery Devices Market

According to a new market research report "Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021" published by MarketsandMarkets™, the market is expected to reach USD 17.85 Billion by 2021 from USD 11.54 Billion in 2016, growing at a CAGR of 9.1%.

Browse 100 market data Tables and 38 Figures spread through 149 Pages and in-depth TOC on "Insulin Delivery Devices Market"

http://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html

Early buyers will receive 10% customization on this report.
This report analyzes and studies the major market drivers, restraints/challenges, and opportunities for the forecast period of 2016 to 2021. The global Insulin Delivery Devices Market is segmented on the basis of type, end user, and region. On the basis of type, the Insulin Delivery Devices Market is categorized into pens, pumps, pen needles, syringes, and other devices (inhalers, transdermal patches, and jet injectors). In 2016, the insulin pens segment commanded the largest share of the Insulin Delivery Devices Market. The insulin pens segment is further divided into reusable and disposable pens. The reusable pens segment commanded the largest share of the insulin pens market in 2016. This large share can be attributed to its lower price compared to disposable pens, availability of reimbursement in selected countries, and increasing adoption of insulin pens in the Asia-Pacific region. However, the insulin pumps segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of Type 1 diabetes and technological advancements in insulin pumps.

Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=107632092

On the basis of end user, the Insulin Delivery Devices Market is segmented into patients/homecare and hospitals & clinics. The patients/homecare segment commanded the largest share of the market in 2016 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be primarily attributed to the increasing diabetic population and rising healthcare expenditure.
On the basis of region, North America accounted for the largest share of the global Insulin Delivery Devices Market in 2016. In the coming years, the Insulin Delivery Devices Market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising partnerships among the global and local players in Asia-Pacific countries. Moreover, high adoption of insulin pens and approvals for injectable insulin in Japan, increasing government initiatives in Singapore, and amendments in NDSS to broaden patient access to diabetes products in Australia are expected to support the growth of the Asia-Pacific Insulin Delivery Devices Market.

Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=107632092

Key players in the global Insulin Delivery Devices Market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.).

Browse Related Reports:

Infusion Pump Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA, Accessories), Application (Oncology, Diabetes, Gastroenterology, Analgesia, Pediatrics, Hematology) & End User (Hospital, Home care) - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/infusion-pumps-accessories-market-90374506.html


About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Visit our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
 

Lithotripsy Devices Market statistics and research analysis released in latest report

According to the new market research report "Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023", The lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Factors such as the growing incidence of urolithiasis and technological advancements in lithotripsy devices are driving the growth of this market.

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lithotripsy-device-market-29769904.html

Kidney stones segment accounted for the largest share in 2017
On the basis of applications, the Lithotripsy Devices Market is categorized into kidney stones, ureteral stones, pancreatic stones, and bile duct stones. In 2017, the kidney stones segment accounted for the largest share of the market. The increasing incidence of kidney stones and the recurrence of these stones over a period of time are the key factors driving the growth of this segment.

North America commanded the largest share of the market in 2017
Based on region, the Lithotripsy Devices Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominated the Lithotripsy Devices Market in 2017. The large share can primarily be attributed to the high prevalence of kidney stones and the large number of surgeries performed each year.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=29769904

In 2017, the hospitals segment accounted for the largest share of the market
On the basis of end user, the Lithotripsy Devices Market is categorized into hospitals, ambulatory surgical centers, and other end users. In 2017, the hospitals segment accounted for the largest share of the global Lithotripsy Devices Market. The large share can be attributed to the high number of surgeries performed in hospitals.


Some of the major players in the Lithotripsy Devices Market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany).